Patent directory · USPTO A61K / A61P
Patents matching “Biotherapeutics, Inc.”
156 pharma patents match "Biotherapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 156 pharmaceutical patents matching "Biotherapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12390453
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
granted -
US 12383572
Administration of an anti-activin-a compound to a subject
granted -
US 12343380
Expansion of TILs utilizing AKT pathways inhibitors
granted -
US 12336983
Inhibition of crystal growth of roflumilast
granted -
US 12329751
Topical roflumilast formulation having antifungal properties
granted -
US 12325750
Anti-Dectin-2 antibodies and methods of using
granted -
US 12310956
Topical roflumilast formulation having improved delivery and plasma half-life
granted -
US 12280140
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
granted -
US 12257242
Inhibition of crystal growth of roflumilast
granted -
US 12233075
Remnant tumor infiltrating lymphocytes and methods of preparing and using the same
granted -
US 12230379
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12226434
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12230378
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12220409
Roflumilast formulations with an improved pharmacokinetic profile
granted -
US 12194061
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12188048
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
US 12170134
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12161643
Stable formulations of SHR0302
granted -
US 12159700
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12144802
Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug
granted -
US 12121541
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12104172
Processes for generating TIL products enriched for tumor antigen-specific t-cells
granted -
US 12083122
Laureth-4 containing topical formulations
granted -
US 12053481
Compositions and methods for deep dermal drug delivery
granted